Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD

Transplantation

Volumn 74, Issue 7, 2002, Pages 951-960

  Schuurman, Henk Jan ^a,b   Menninger, Klaus ^a   Audet, Maxime ^a   Kunkler, Adrien ^a   Maurer, Claudine ^a   Vedrine, Corinne ^a   Bernhard, Mario ^a   Gaschen, Lorrie ^a   Brinkmann, Volker ^a   Quesniaux, Valerie ^a,c  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Immerge Biotherapeutics Inc   (United States)

^c Experimental and Molecular Genetics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FINGOLIMOD; RAPAMYCIN DERIVATIVE;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENTIATION; DRUG TOLERABILITY; GRAFT REJECTION; GRAFT SURVIVAL; HYPOPHOSPHATEMIA; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOID ORGAN; MONKEY; NEPHRECTOMY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOSIS; WEIGHT REDUCTION;

EID: 0037108893     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200210150-00009     Document Type: Article

References (20)

1. Brinkmann V, Pinschewer DD, Feng L, et al. FTY720: altered lymphocyte traffic results in allograft protection. Transplantation 2001; 72: 764.
2. Troncoso P, Stepkowski SM, Wang M-E, et al. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine. Transplantation 1999; 67: 145.
3. Schuler W, Sedrani R, Cottens S, et al. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 1997; 64: 36.
4. Schuurman H-J, Ringers J, Schuler W, et al. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomo]gus cynomolg-us monkey kidney allotransplantation. Transplantation 2000; 69: 737.
5. Schuurman H-J, Slingerland W, Mennninger K, et al. Pharmacokinetics of cyclosporine in monkeys after oral and intramuscular administration: relation to efficacy in kidney allografting. Transpl Int 2001; 14: 320.
6. Quesniaux V, Menninger K, Audet M, et al. FTY-720 is efficacious in monkey kidney transplantation. Transplant Proc 2001; 33: 2374.
7. Quesniaux V, Fullard L, Arendse H, et al. A novel immunosuppressant, FTY720, induces peripheral lymphodepletion of both T- and B-cells and immunosuppression in baboons. Transpl Immunol 1999; 7: 149.
8. Quesniaux V, Menninger K, Kunkler A, et al. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with cyclosporine Neoral or with RAD. Transpl Immunol 2000; 8: 177.
9. Socha WW, Blancher A, Moor-Jankowski J. Red cell polymorphism in nonhuman primates, a review. J Med Primatol 1995; 24: 282.
10. Knapp LA, Lehmann E, Hennes L, et al. High-resolution HLA-DRB typing using denaturating gradient gel electrophoresis and direct sequencing. Tissue Antigens 1997; 50: 170.
11. Gaschen L, Audet M, Menninger K, et al. Ultrasonographic findings of functioning renal allografts in the cynomolgus monkey (Macaca fascicularis). J Med Primatol 2001; 30: 46.
12. Gaschen L, Schuurman H-J. Contribution of Power Doppler sonography to the detection of renal allograft rejection in the cynomolgus monkey. Invest Radiol 2001; 36: 335.
13. Gaschen L, Kunkler A, Menninger K, et al. Safety of percutaneous ultrasound-guided biopsy of renal allografts in the cynomolgus monkey: results of 348 consecutive biopsies. Vet Radiol Ultrasound 2001; 42: 259.
14. McInnes EF, Jarrett RF, Langford G, et al. Post-transplant lympho-proliferative disorder associated with primate gamma-herpesvirus in cynomolgus monkeys used in pig-to-primate renal xenotransplantation and primate renal allotransplantation. Transplantation 2002; 73: 44.
15. Berenbaum MC. Synergy, additivism and antagonism in immunosuppression. Clin Exp Immunol 1977; 28: 1.
16. Kahan BD. Synergism, how assessed and how achieved. Clin Transpl 1991; 5: 534.
17. Chou TC, Stepkowski SM, Kahan BD. Computerized quantitation of immunosuppressive synergy for clinical protocol design. Transplant Proc 1994; 26: 3043.
18. Graler MH, Bernhardt G, Lipp M. A lymphoid tissue-specific receptor, EDG6, with potential immune modulatory functions mediated by extracellular lysophospholipids. Curr Top Microbiol Immunol 1999; 246: 131.
19. Brinkmann V, Davis MD, Heise CE, et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 2002; 277: 21453.
20. Mandala S, Hajdu R, Bergstrom J, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002 296 346.